Showing results (11-20 of 638) with videos related to
Sort By:
Pageof 64
Haematologica|March 1, 1995
The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemiaD Diverio, R Riccioni, F Mandelli, et al.Oncogene|June 23, 2001
Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?S Minucci, C Nervi, F Lo Coco, et al.Current Opinion in Oncology|February 1, 1992
Biology and treatment of multiple myelomaF Mandelli, G Avvisati, M TribaltoBailliere'S Clinical Haematology|March 1, 1994
The interferons in haematological malignanciesF Mandelli, W Arcese, G AvvisatiAnnals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 1998
The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged > 60 yearsR Latagliata, G Avvisati, F Lo Coco, et al.Bailliere'S Clinical Haematology|December 1, 1995
The role of biotherapies (interleukins, interferons and erythropoietin) in multiple myelomaG Avvisati, M T Petrucci, F MandelliLeukemia & Lymphoma|January 1, 1993
What is the best treatment for acute promyelocytic leukemia?G Avvisati, M C Petti, F MandelliLeukemia|August 26, 2006
Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular featuresM Breccia, G Avvisati, R Latagliata, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'AdultoG Specchia, F Lo Coco, M Vignetti, et al.Drugs|June 1, 1997
Current guidelines for the management of aggressive non-Hodgkin's lymphomaM Martelli, V De Sanctis, G Avvisati, et al.Pageof 64